(Q34890595)

5 August 2017

title

Predicting response to immunosuppressive therapy in childhood aplastic anemia (English)

1 reference

5 August 2017

Nao Yoshida

1

1 reference

5 August 2017

Hiroshi Yagasaki

2

1 reference

5 August 2017

Asahito Hama

3

1 reference

5 August 2017

Yoshiyuki Takahashi

4

1 reference

5 August 2017

Yoshiyuki Kosaka

5

1 reference

5 August 2017

Ryoji Kobayashi

6

1 reference

5 August 2017

Hiromasa Yabe

7

1 reference

5 August 2017

Takashi Kaneko

8

1 reference

5 August 2017

Masahiro Tsuchida

9

1 reference

5 August 2017

Akira Ohara

10

1 reference

5 August 2017

Tatsutoshi Nakahata

11

1 reference

5 August 2017

Seiji Kojima

12

1 reference

5 August 2017

publication date

27 January 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

96

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

771-774

1 reference

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

8 July 2018

Acquired aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3084926

Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia

26 October 2018

1 reference

12 December 2020

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

1 reference

12 December 2020

HLA-DRB1*15 and pediatric aplastic anemia

1 reference

12 December 2020

Bone marrow graft in man after conditioning by antilymphocytic serum

1 reference

12 December 2020

Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia

1 reference

12 December 2020

Further evidence for lymphokine overproduction in severe aplastic anemia

1 reference

12 December 2020

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

12 December 2020

Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia

1 reference

12 December 2020

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party

1 reference

12 December 2020

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

1 reference

12 December 2020

Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia

1 reference

12 December 2020

10.3324/HAEMATOL.2010.032805

Identifiers

DOI

1 reference

release_sasjtswnlbctvn7blcxcyu3y5m

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sasjtswnlbctvn7blcxcyu3y5m

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3084926

1 reference

5 August 2017

1 reference